BAM
ABMD

Blueshift Asset Management’s Abiomed Inc ABMD Stock Holding History

Blueshift Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-831
Closed -$204K – 710
2022
Q3 		$204K Buy
+831
New +$224K 0.04% 512
2022
Q2 		– Sell
-949
Closed -$314K – 1084
2022
Q1 		$314K Buy
+949
New +$292K 0.03% 597
2021
Q4 		– Sell
-1,157
Closed -$377K – 1324
2021
Q3 		$377K Sell
1,157
-198
-15% -$67.1K 0.02% 731
2021
Q2 		$423K Buy
+1,355
New +$416K 0.02% 620
2020
Q1 		– Sell
-8,510
Closed -$1.45M – 762
2019
Q4 		$1.45M Buy
8,510
+5,975
+236% +$1.11M 0.17% 183
2019
Q3 		$451K Buy
+2,535
New +$548K 0.07% 399
2019
Q2 		– Sell
-2,298
Closed -$656K – 1025
2019
Q1 		$656K Buy
+2,298
New +$764K 0.09% 345

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Blueshift Asset Management's ABMD Position: Q4 2022 in Review

Blueshift Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 831 shares — an estimated $204K sold.

Blueshift Asset Management first reported a position in ABMD in Q1 2019 and held it in 7 quarters. The position peaked at $1.45M in Q4 2019. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Blueshift Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Blueshift Asset Management sold 831 Abiomed Inc shares in Q4 2022, an estimated $204K.
  • Blueshift Asset Management first reported a position in Abiomed Inc in Q1 2019 and held it in 7 quarters.
  • Blueshift Asset Management's Abiomed Inc position peaked at $1.45M in Q4 2019.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Blueshift Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.